Showing results (81-90 of 89) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Blood Advances|April 19, 2024
Multicenter, phase 1 study of etavopivat (FT-4202) treatment for up to 12 weeks in patients with sickle cell diseaseSantosh L Saraf, Robert Hagar, Modupe Idowu, et al.Experimental Hematology|November 16, 2024
FT-4202, a selective pyruvate kinase R activator for sickle cell diseaseAnna Ericsson, David J Richard, Erik Wilker, et al.Blood Cells, Molecules & Diseases|January 21, 2012
A transgenic mouse model expressing exclusively human hemoglobin E: indications of a mild oxidative stressQiuying Chen, Mary E Fabry, Anne C Rybicki, et al.British Journal of Haematology|August 19, 2011
Tapered oral dexamethasone for the acute chest syndrome of sickle cell diseaseCharles T Quinn, Marie J Stuart, Karen Kesler, et al.British Journal of Haematology|April 25, 2015
Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemiaClaudia R Morris, Hae-Young Kim, Elizabeth S Klings, et al.American Journal of Physiology. Cell Physiology|August 19, 2011
Loss-of-function and gain-of-function phenotypes of stomatocytosis mutant RhAG F65SAndrew K Stewart, Boris E Shmukler, David H Vandorpe, et al.Haematologica|April 16, 2013
Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertensionClaudia R Morris, Hae-Young Kim, John Wood, et al.Journal of Lipid Research|August 5, 2004
Revised nomenclature for the mammalian long-chain acyl-CoA synthetase gene familyDouglas G Mashek, Karin E Bornfeldt, Rosalind A Coleman, et al.Nature Medicine|June 27, 2006
VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesisBetty Y Y Tam, Kevin Wei, John S Rudge, et al.Pageof 9